Ampiplus

Medicinal product

(Invented) name

Ampiplus

Active substance (s)

Ampicilinas/Sulbaktamas

Strength

1000 mg/500 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR01, Ampicillin and beta-lactamase inhibitor

Marketing authorisation holder

UAB Ideal Trade Links, Lietuva

Date of authorisation

2026-07-27

Date of renewal

Documents

3540_Ampiplus 1000mg-500mg_PZ_2026-07-27.docx

3540_Ampiplus 1000mg-500mg_PL_2026-07-27.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra	1 vnt.
Ampicilinas	1000 mg
Sulbaktamas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121693	107802	1107802	flakonas	N1		Receptinis	LT/L/26/3540/001	Netiekiama	-	-	No	-	-
121694	107803	1107803	flakonas	N10		Receptinis	LT/L/26/3540/002	Netiekiama	-	-	No	-	-
121695	107804	1107804	flakonas	N25		Receptinis	LT/L/26/3540/003	Netiekiama	-	-	No	-	-	Download
121696	107805	1107805	flakonas	N50		Receptinis	LT/L/26/3540/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-07-27	Registruotas